We are live on ! Find out more
CCC

Chelsea Counsel Company Portfolio holdings

AUM $236M
1-Year Est. Return 51.76%
This Fund
S&P 500
This Quarter Est. Return
-2.53%
1 Year Est. Return
+51.76%
3 Year Est. Return
+106.38%
5 Year Est. Return
+132.3%
10 Year Est. Return
+407.64%
AUM
$501M
AUM Growth
-$11.1M
Cap. Flow
+$6.86M
Cap. Flow %
1.37%
Top 10 Hldgs %
35.71%
Holding
145
New
16
Increased
51
Reduced
29
Closed
10

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$9.5M
2
NOV icon
NOV
NOV
+$481K
3
GS icon
Goldman Sachs
GS
+$385K
4
APA icon
APA Corp
APA
+$352K
5
COST icon
Costco
COST
+$303K

Sector Composition

Rank Sector Weight
1 Energy 24.23%
2 Industrials 20.05%
3 Consumer Staples 11.68%
4 Communication Services 10.12%
5 Healthcare 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIDU icon
101
Baidu
BIDU
$30.9B
$298K 0.06%
1,365
UAA icon
102
Under Armour
UAA
$2.13B
$297K 0.06%
+8,600
New +$287K
ECL icon
103
Ecolab
ECL
$77B
$287K 0.06%
2,500
WFC icon
104
Wells Fargo
WFC
$271B
$282K 0.06%
5,434
-1,400
-20% -$72K
CXO
105
DELISTED
CONCHO RESOURCES INC.
CXO
$276K 0.06%
+2,200
New +$301K
UPS icon
106
United Parcel Service
UPS
$87.1B
$265K 0.05%
+2,699
New +$268K
DD
107
DELISTED
Du Pont De Nemours E I
DD
$259K 0.05%
3,801
-411
-10% -$25.9K
MCD icon
108
McDonald's
MCD
$179B
$255K 0.05%
+2,694
New +$257K
SCE.PRE
109
DELISTED
Southern California Edison Company 4.78% Cum. Pfd.
SCE.PRE
$251K 0.05%
10,667
GTU
110
DELISTED
CENTRAL GOLD TR (CANADA)
GTU
$251K 0.05%
6,060
-2,750
-31% -$124K
ELV icon
111
Elevance Health
ELV
$90.6B
$239K 0.05%
2,000
MO icon
112
Altria Group
MO
$117B
$239K 0.05%
+5,195
New +$223K
FFIV icon
113
F5
FFIV
$24.4B
$237K 0.05%
2,000
AMZN icon
114
Amazon
AMZN
$2.68T
$226K 0.05%
14,000
BP icon
115
BP
BP
$121B
$222K 0.04%
6,174
-611
-9% -$24.2K
BAX icon
116
Baxter International
BAX
$12.3B
$221K 0.04%
+5,665
New +$230K
SJM icon
117
J.M. Smucker
SJM
$13B
$220K 0.04%
2,227
KRFT
118
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$219K 0.04%
+3,890
New +$225K
V icon
119
Visa
V
$701B
$213K 0.04%
4,000
-4,000
-50% -$215K
SNY icon
120
Sanofi
SNY
$102B
$212K 0.04%
+3,750
New +$201K
BMY icon
121
Bristol-Myers Squibb
BMY
$130B
$210K 0.04%
+4,104
New +$205K
IMUC
122
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$25K 0.01%
700
RCPI
123
DELISTED
ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
$5K ﹤0.01%
652
APA icon
124
APA Corp
APA
$16.6B
-3,500
Closed -$352K
GS icon
125
Goldman Sachs
GS
$284B
-2,300
Closed -$385K

Similar funds

Chelsea Counsel Company's Q3 2014 Portfolio in Review

As of Q3 2014, Chelsea Counsel Company held 145 positions worth $501M, down 2.2% from $512M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Chelsea Counsel Company's Q3 2014 filing shows 16 new, 51 increased, 29 reduced and 10 closed positions. Its largest new stake was Intel: 13,973 shares worth $487K. The largest sale was AbbVie, an estimated $9.5M.

By sector, the portfolio is most concentrated in Energy at 24% of assets, down from 26% a quarter earlier, followed by Industrials and Consumer Staples.

  • Chelsea Counsel Company's largest Q3 2014 buy was Intel: 13,973 shares worth $487K.
  • Chelsea Counsel Company added most to Unilever NV New York Registry Shares in Q3 2014, an estimated $7.56M increase.
  • Chelsea Counsel Company's biggest Q3 2014 reduction was AbbVie, cutting an estimated $9.5M.
  • Chelsea Counsel Company fully exited NOV in Q3 2014, selling an estimated $481K.
  • Chelsea Counsel Company's ten largest holdings make up 36% of its $501M portfolio in Q3 2014.
  • Chelsea Counsel Company opened 16 new positions and closed 10 in Q3 2014.
  • Chelsea Counsel Company's portfolio value fell 2.2% quarter-over-quarter to $501M.

Based on Chelsea Counsel Company's 13F filing for Q3 2014, filed 16 Dec 2014.